Clinical Trial
doi: 10.1016/s0140-6736(75)90235-4.
Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation
- PMID: 53330
- DOI: 10.1016/s0140-6736(75)90235-4
Item in Clipboard
Clinical Trial
Controlled trial of bromocriptine, quinoestrol, and placebo in suppression of puerperal lactation
Lancet.
.
Abstract
2-bromo-alpha-ergocryptine (bromocriptine) in a dosage of 2-5 mg twice daily caused a rapid fall in plasma prolactin. It was more effective than either a single dose of 4 mg quinoestrol or a placebo in suppressing puerperal lactation, as judged by milk flow and the relief of breast pain and congestion. Patients who received quinoestrol were more comfortable than those who received placebo.
Similar articles
-
Use of bromocriptine in the inhibition of puerperal lactation.Drugs. 1979 May;17(5):326-36. doi: 10.2165/00003495-197917050-00002. Drugs. 1979. PMID: 378648 Review. No abstract available.
-
A comparison of 2 bromo alpha ergocryptine, quinoestrol and placebo in suppression of puerperal lactation [proceedings].Br J Clin Pharmacol. 1975 Aug;2(4):368P-369P. doi: 10.1111/j.1365-2125.1975.tb02790.x. Br J Clin Pharmacol. 1975. PMID: 788734 Clinical Trial. No abstract available.
-
The suppression of puerperal lactation with bromocriptine.Ir Med J. 1977 Apr 9;70(5):172-3. Ir Med J. 1977. PMID: 324946 Clinical Trial. No abstract available.
-
The suppression of puerperal lactation with bromocryptine.Acta Obstet Gynecol Scand. 1977;56(2):145-9. doi: 10.3109/00016347709158357. Acta Obstet Gynecol Scand. 1977. PMID: 324230 Clinical Trial.
-
Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.Drugs. 1995 Feb;49(2):255-79. doi: 10.2165/00003495-199549020-00009. Drugs. 1995. PMID: 7729332 Review.
Cited by
-
Use of bromocriptine in the inhibition of puerperal lactation.Drugs. 1979 May;17(5):326-36. doi: 10.2165/00003495-197917050-00002. Drugs. 1979. PMID: 378648 Review. No abstract available.
-
Therapeutic applications of bromocriptine in endocrine and neurological diseases.Drugs. 1988 Jul;36(1):67-82. doi: 10.2165/00003495-198836010-00005. Drugs. 1988. PMID: 3063495 Review.
-
Repositioning Dopamine D2 Receptor Agonist Bromocriptine to Enhance Docetaxel Chemotherapy and Treat Bone Metastatic Prostate Cancer.Mol Cancer Ther. 2018 Sep;17(9):1859-1870. doi: 10.1158/1535-7163.MCT-17-1176. Epub 2018 Jun 15. Mol Cancer Ther. 2018. PMID: 29907594 Free PMC article.
-
Treatments for suppression of lactation.Cochrane Database Syst Rev. 2012 Sep 12;2012(9):CD005937. doi: 10.1002/14651858.CD005937.pub3. Cochrane Database Syst Rev. 2012. PMID: 22972088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
